NeuraLace Medical is a US-based startup focused on revolutionizing chronic pain relief. Founded in 2016, the company's slogan, "Beyond Chronic Pain," encapsulates its mission to provide sustainable, non-invasive solutions. NeuraLace challenges conventional healthcare thinking and aims to maximize pain relief while minimizing side effects. The company distinguishes itself as both a device developer and a medical technology company, emphasizing innovation and technical prowess. Its recent Series A investment in September 2021, led by Colibri Equity Management and Défense Angels, signifies growing investor confidence in its vision. NeuraLace Medical is poised to make a meaningful impact in the field of pain therapeutics with its unique approach and strategic partnerships.
No recent news or press coverage available for Neuralace Medical.